These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 23553131)

  • 1. Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review.
    Serý O; Povová J; Míšek I; Pešák L; Janout V
    Folia Neuropathol; 2013; 51(1):1-9. PubMed ID: 23553131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.
    Ihara M; Washida K
    J Alzheimers Dis; 2018; 62(1):61-72. PubMed ID: 29439352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.
    Stefanova NA; Maksimova KY; Rudnitskaya EA; Muraleva NA; Kolosova NG
    BMC Genomics; 2018 Feb; 19(Suppl 3):75. PubMed ID: 29504901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenesis of Alzheimer's disease: molecular and cellular mechanisms].
    Govaerts L; Schoenen J; Bouhy D
    Rev Med Liege; 2007 Apr; 62(4):209-16. PubMed ID: 17566391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the complex pathology of Alzheimer's disease in Drosophila.
    Fernandez-Funez P; de Mena L; Rincon-Limas DE
    Exp Neurol; 2015 Dec; 274(Pt A):58-71. PubMed ID: 26024860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
    Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM
    Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (II)].
    Toledano A; Álvarez MI; López-Rodríguez AB; Toledano-Díaz A; Fernández-Verdecia CI
    Neurologia; 2014; 29(1):42-55. PubMed ID: 21871692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alois Alzheimer and Alzheimer's disease: a centennial perspective.
    Small DH; Cappai R
    J Neurochem; 2006 Nov; 99(3):708-10. PubMed ID: 17076655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic models of Alzheimer's disease: learning from animals.
    Spires TL; Hyman BT
    NeuroRx; 2005 Jul; 2(3):423-37. PubMed ID: 16389306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease.
    Oliveira J; Costa M; de Almeida MSC; da Cruz E Silva OAB; Henriques AG
    J Alzheimers Dis; 2017; 58(4):953-978. PubMed ID: 28527217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer culprits: cellular crossroads and interplay.
    Claeysen S; Cochet M; Donneger R; Dumuis A; Bockaert J; Giannoni P
    Cell Signal; 2012 Sep; 24(9):1831-40. PubMed ID: 22627093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: as it was in the beginning.
    Kozlov S; Afonin A; Evsyukov I; Bondarenko A
    Rev Neurosci; 2017 Nov; 28(8):825-843. PubMed ID: 28704198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
    Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
    J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: a general introduction and pathomechanism.
    Finder VH
    J Alzheimers Dis; 2010; 22 Suppl 3():5-19. PubMed ID: 20858960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.